U.S. flag

An official website of the United States government

Display Settings:

Items per page

PMC Full-Text Search Results

Items: 7

1.
Figure 5

Figure 5. Distinction between activation and delayed repression. From: Contrasting behavior of the p18INK4c and p16INK4a tumor suppressors in both replicative and oncogene-induced senescence.

A. A validated shRNA was used to knockdown p16INK4a in several strains of logarithmically growing HDFs and its effects on p16INK4a and p18INK4c were assessed by immunoblotting. B. Lifespan extension in TIG3 cells infected with a retrovirus encoding mouse Bmi1 compared to empty vector (Vec). C. The cells described in panel B were harvested at the indicated days post-infection and the levels of p16INK4a and p18INK4c were assessed by immunoblotting. D. Direct comparison of lysates prepared at days 50 and 64 (indicated by the arrows in panel B) from cells infected with Bmi1 virus (+) or empty vector (−).

Sladjana Gagrica, et al. Cancer Res. ;72(1):165-175.
2.
Figure 7

Figure 7. p18INK4c is not required for replicative or oncogene induced senescence. From: Contrasting behavior of the p18INK4c and p16INK4a tumor suppressors in both replicative and oncogene-induced senescence.

A. Hs68 cells infected with a retrovirus encoding either shRNA against p18INK4c or a non-specific shRNA (Con) were passaged until they reached M1 senescence. B. Immunoblotting for p18INK4c and p16INK4a in cells infected with p18INK4c shRNA. C. Expression of H-RASG12V in cells transduced with p18INK4c shRNA caused oncogene-induced senescence accompanied by a further reduction of p18INK4c levels and enhanced expression of p16INK4a. D. Lysates from proliferating (P) and senescent (S) fibroblasts were immunoprecipitated with rabbit antibodies against CDK6, CDK4, p18INK4c and p16INK4a. The proteins were fractionated by SDS-PAGE and immunoblotted with mouse monoclonal antibodies against the indicated proteins.

Sladjana Gagrica, et al. Cancer Res. ;72(1):165-175.
3.
Figure 2

Figure 2. Downregulation of INK4c RNA at senescence. From: Contrasting behavior of the p18INK4c and p16INK4a tumor suppressors in both replicative and oncogene-induced senescence.

A and B. The Hs68 (A) and Leiden (B) strains of HDF were passaged to senescence and the relative levels of INK4c RNA in proliferating (P) and senescent (S) cells were assessed by reverse transcription and quantitative real-time PCR (qRT-PCR). C. Relative levels of INK4c and INK4a RNAs in HDFs (Hs68) infected with a retrovirus encoding H-RASG12V or empty vector control (Vec). D. Relative levels of INK4c and INK4a RNAs following addition of tamoxifen (OHT) to HDFs (BF) expressing ER:H-RASG12V. E. Relative levels of INK4c RNA in HDFs (Hs68) transduced with retroviral vectors encoding HA-tagged versions of p16INK4a, p18INK4c or p21CIP1. Note that endogenous INK4c RNA was measured using primer sets that do not detect the ectopically expressed INKc cDNA.

Sladjana Gagrica, et al. Cancer Res. ;72(1):165-175.
4.
Figure 6

Figure 6. Senescence-dependent and -independent downregulation of p18INK4c. From: Contrasting behavior of the p18INK4c and p16INK4a tumor suppressors in both replicative and oncogene-induced senescence.

A. HDFs (Hs68) treated with the CDK4/6 inhibitor PD0332991 were harvested at the indicated intervals and levels of INK4c, B-MYB and CDC6 RNA were assessed by qRT-PCR and normalized to the untreated control. B. HDFs (TIG3) treated with and without PD0332991 for 14d were stained for SA-β-galactosidase activity and with DAPI to visualize SAHFs. C. Lysates from the cells described in panel B were immunoblotted for p18INK4c, p16INK4a, menin, and E2F1 with MEK as a loading control. D. HDFs (BF and Leiden) were infected with a retrovirus encoding H-RASG12V or empty vector and the relative levels of INK4c and INK4a RNA were assessed by qRT-PCR and normalized to the vector only control. E. Lysates from the cells described in panel D were immunoblotted for p18INK4c and p16INK4a. F. Lysates from Leiden cells infected with a retrovirus encoding H-RASG12V or empty vector were immunoblotted for menin, E2F1, p18INK4c and RAS.

Sladjana Gagrica, et al. Cancer Res. ;72(1):165-175.
5.
Figure 1

Figure 1. Downregulation of p18INK4c at senescence. From: Contrasting behavior of the p18INK4c and p16INK4a tumor suppressors in both replicative and oncogene-induced senescence.

A. HDFs (TIG3) were passaged continuously until they reached replicative senescence (Sen). Cell lysates prepared at the indicated population doublings (PD) were fractionated by SDS-PAGE and immunoblotted for p16INK4a, p21CIP1 and p18INK4c. Right panel shows a direct comparison between proliferating (P) and senescent (S) cells. B. HDFs (TIG3) were infected with a retrovirus encoding H-RASG12V or the empty vector control (Vec). Following drug selection, the levels of p18INK4c and p16INK4a were assessed by immunoblotting. C. Primary MEFs were infected with a retrovirus encoding H-RASG12V or the empty vector control (Vec). The levels of p18Ink4c and p16Ink4a were assessed by immunoblotting. D. HDFs (Hs68) were infected with a retrovirus encoding HA-tagged p16INK4a. The levels of p18INK4c and p16INK4a were assessed by immunoblotting. E. MG132 had no effect on p18INK4c levels in cells transduced with HA-p16INK4a or empty vector. F. The Leiden strain of p16INK4a-deficient fibroblasts were passaged until they reached senescence. Samples taken at the indicated PDs were immunoblotted for p18INK4c, with CDK4 as a loading control.

Sladjana Gagrica, et al. Cancer Res. ;72(1):165-175.
6.
Figure 4

Figure 4. Regulation of p18INK4c by E2F1. From: Contrasting behavior of the p18INK4c and p16INK4a tumor suppressors in both replicative and oncogene-induced senescence.

A. Relative levels of INK4c, INK4a and CDC6 RNAs in Hs68 cells infected with a retrovirus encoding SV40 large T-Ag (LT) or empty vector control (Vec) (left panel). Lysates from the same cells were fractionated by SDS-PAGE and immunoblotted for p18INK4c and p16INK4a as indicated (right). B. Survey of p18INK4c and p16INK4a expression in a series of human cancer cell lines from different anatomical sites: breast (T47D, BT5499, ZR75-1 MDA-MB468 and MCF7), keratinocyte (HaCaT), bladder (K5637 and T24), cervix (C33A), bone (U2OS) and prostate (DU145 and PC3). The +/− below each lane refers to the functional status of the RB1 gene in these cell lines, based on published literature. CDK4 was used as a loading control. C. Comparison of E2F1 RNA (left) and protein (right) levels in proliferating (P) and senescent (S) HDFs (TIG3). D. Comparison of INK4c and E2F1 RNA expression in HDFs (IMR90) infected with a retrovirus encoding H-RASG12V (Ras) or empty vector (Vec). E. Down-regulation of E2F1 protein in HDFs (TIG3) cells transduced with H-RASG12V. F. Down-regulation of E2F1 in HDFs infected with a retrovirus encoding HA-p16INK4a.

Sladjana Gagrica, et al. Cancer Res. ;72(1):165-175.
7.
Figure 3

Figure 3. Role of menin in the down-regulation of INK4c. From: Contrasting behavior of the p18INK4c and p16INK4a tumor suppressors in both replicative and oncogene-induced senescence.

A. Diagram of the human INK4c locus with exons depicted as boxes and coding domains shaded. The location of the transcriptional start sites (arrows) and primer sets P1-P6 used for ChIP analyses are indicated. B. ChIP of menin and H3K4me3 at the INK4c locus before and after treatment of IMR90 ER:RAS cells with OHT. Enrichment for each primer set was assessed by qPCR relative to a non-specific IgG and expressed as percentage of input. C and D. Comparison of MEN1 and INK4c RNA levels in proliferating (P) and senescent (S) populations of Hs68 (C) and Leiden (D) fibroblasts (same samples as in ). E. Relative levels of MEN1 and INK4c RNA in cells transduced with retroviral vectors encoding HA-tagged versions of p16INK4a, p18INK4c or p21CIP1, as in . F. Relative levels of INK4c, MEN1 and INK4a RNAs in Hs68 cells infected with a retrovirus encoding H-RASG12V or empty vector control (Vec), as in . G. Relative levels of INK4c, MEN1 and INK4a RNAs following addition of tamoxifen (OHT) to BF cells expressing ER:H-RASG12V (as in ).

Sladjana Gagrica, et al. Cancer Res. ;72(1):165-175.

Display Settings:

Items per page

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center